Multicenter, phase II study of trastuzumab and paclitaxel to treat HER2-positive, metastatic gastric cancer patients naive to trastuzumab (JFMC45-1102).
Satoru Iwasa
No relevant relationships to disclose
Kazuhiro Nishikawa
No relevant relationships to disclose
Akira Miki
No relevant relationships to disclose
Hirokazu Noshiro
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose
Yasunori Nishida
No relevant relationships to disclose
Hiroto Miwa
No relevant relationships to disclose
Toshiki Masuishi
No relevant relationships to disclose
Kazuhiro Yoshida
No relevant relationships to disclose
Yasuhiro Kodera
No relevant relationships to disclose
Narikazu Boku
No relevant relationships to disclose
Yasuhide Yamada
No relevant relationships to disclose
Satoshi Morita
No relevant relationships to disclose
Junichi Sakamoto
No relevant relationships to disclose
Shigetoyo Saji
No relevant relationships to disclose
Yuko Kitagawa
No relevant relationships to disclose